◆英語タイトル：Foamix Pharmaceuticals Ltd (FOMX) - Financial and Strategic SWOT Analysis Review
Foamix Pharmaceuticals Ltd (Foamix), formerly Foamix Ltd is a pharmaceutical company that develops and commercializes proprietary topical drugs for various dermatological therapies. The company’s product candidates include FMX101, a minocycline foam which is intended for the treatment of moderate-to-severe acne; FMX 103, for the treatment of rosacea; FMX102, for impetigo; and FDX104, a doxycycline foam for the management of acne-like rash. It also develops various early stage products. The company has partnership with various pharmaceutical companies to develop its product candidates. It has presence in Israel and the US. Foamix is headquartered in Rehovot, Israel.
Foamix Pharmaceuticals Ltd Key Recent Developments
Jan 23,2019: Foamix names Sharon Barbari as Board Director
Jan 23,2019: Foamix names Sharon Barbari as Board Director
Nov 27,2018: Foamix names Wiley to newly-created role of chief commercial officer
Nov 27,2018: Foamix Pharmaceuticals names Matt Wiley as Chief Commercial Officer
This comprehensive SWOT profile of Foamix Pharmaceuticals Ltd provides you an in-depth strategic analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses and the potential opportunities and threats. The profile helps you formulate strategies that augment your business by enabling you to understand your partners, customers and competitors better.
This company report forms part of GlobalData’s ‘Profile on Demand’ service, covering over 50,000 of the world’s leading companies. Once purchased, GlobalData’s highly qualified team of company analysts will comprehensively research and author a full financial and strategic analysis of Foamix Pharmaceuticals Ltd including a detailed SWOT analysis, and deliver this direct to you in pdf format within two business days. (excluding weekends).
The profile contains critical company information including*,
- Business description – A detailed description of the company’s operations and business divisions.
- Corporate strategy – Analyst’s summarization of the company’s business strategy.
- SWOT Analysis – A detailed analysis of the company’s strengths, weakness, opportunities and threats.
- Company history – Progression of key events associated with the company.
- Major products and services – A list of major products, services and brands of the company.
- Key competitors – A list of key competitors to the company.
- Key employees – A list of the key executives of the company.
- Executive biographies – A brief summary of the executives’ employment history.
- Key operational heads – A list of personnel heading key departments/functions.
- Important locations and subsidiaries – A list and contact details of key locations and subsidiaries of the company.
- Key manufacturing facilities – A list of key manufacturing facilities of the company.
- Detailed financial ratios for the past five years – The latest financial ratios derived from the annual financial statements published by the company with 5 years history.
- Interim ratios for the last five interim periods – The latest financial ratios derived from the quarterly/semi-annual financial statements published by the company for 5 interims history.
Note*: Some sections may be missing if data is unavailable for the company.
Key benefits of buying this profile include,
You get detailed information about the company and its operations to identify potential customers and suppliers.
- The profile analyzes the company’s business structure, operations, major products and services, prospects, locations and subsidiaries, key executives and their biographies and key competitors.
Understand and respond to your competitors’ business structure and strategies, and capitalize on their weaknesses. Stay up to date on the major developments affecting the company.
- The company’s core strengths and weaknesses and areas of development or decline are analyzed and presented in the profile objectively. Recent developments in the company covered in the profile help you track important events.
Equip yourself with information that enables you to sharpen your strategies and transform your operations profitably.
- Opportunities that the company can explore and exploit are sized up and its growth potential assessed in the profile. Competitive and/or technological threats are highlighted.
Scout for potential investments and acquisition targets, with detailed insight into the companies’ strategic, financial and operational performance.
- Financial ratio presented for major public companies in the profile include the revenue trends, profitability, growth, margins and returns, liquidity and leverage, financial position and efficiency ratios.
Gain key insights into the company for academic or business research.
- Key elements such as SWOT analysis, corporate strategy and financial ratios and charts are incorporated in the profile to assist your academic or business research needs.
Table of Contents
Section 1 – About the Company
Foamix Pharmaceuticals Ltd – Key Information
Foamix Pharmaceuticals Ltd – Overview
Foamix Pharmaceuticals Ltd – Key Employees
Foamix Pharmaceuticals Ltd – Key Employee Biographies
Foamix Pharmaceuticals Ltd – Key Operational Heads
Foamix Pharmaceuticals Ltd – Major Products and Services
Foamix Pharmaceuticals Ltd – History
Foamix Pharmaceuticals Ltd – Company Statement
Foamix Pharmaceuticals Ltd – Locations And Subsidiaries
Foamix Pharmaceuticals Ltd – Key Manufacturing facilities
Other Locations & Subsidiaries
Section 2 – Company Analysis
Foamix Pharmaceuticals Ltd – Business Description
Foamix Pharmaceuticals Ltd – Corporate Strategy
Foamix Pharmaceuticals Ltd – SWOT Analysis
SWOT Analysis – Overview
Foamix Pharmaceuticals Ltd – Strengths
Foamix Pharmaceuticals Ltd – Weaknesses
Foamix Pharmaceuticals Ltd – Opportunities
Foamix Pharmaceuticals Ltd – Threats
Foamix Pharmaceuticals Ltd – Key Competitors
Section 3 – Company Financial Performance Charts
Foamix Pharmaceuticals Ltd – Financial Ratios
Financial Ratios – Capital Market Ratios
Financial Ratios – Annual Ratios
Financial Ratios – Interim Ratios
Financial Ratios – Ratio Charts
Section 4 – Appendix
Note*: Some sections may be missing if data is unavailable for the company
List of Tables
Foamix Pharmaceuticals Ltd, Key Information
Foamix Pharmaceuticals Ltd, Key Ratios
Foamix Pharmaceuticals Ltd, Share Data
Foamix Pharmaceuticals Ltd, Major Products and Services
Foamix Pharmaceuticals Ltd, History
Foamix Pharmaceuticals Ltd, Key Employees
Foamix Pharmaceuticals Ltd, Key Employee Biographies
Foamix Pharmaceuticals Ltd, Key Operational Heads
Foamix Pharmaceuticals Ltd, Other Locations
Foamix Pharmaceuticals Ltd, Subsidiaries
Foamix Pharmaceuticals Ltd, Key Manufacturing facilities
Foamix Pharmaceuticals Ltd, Key Competitors
Foamix Pharmaceuticals Ltd, SWOT Analysis
Foamix Pharmaceuticals Ltd, Ratios based on current share price
Foamix Pharmaceuticals Ltd, Annual Ratios
Foamix Pharmaceuticals Ltd, Interim Ratios
Capital Market Ratios
List of Figures
Foamix Pharmaceuticals Ltd, Performance Chart
Foamix Pharmaceuticals Ltd, Ratio Charts
| ★海外企業調査レポート[Foamix Pharmaceuticals Ltd (FOMX)：企業の財務・戦略的SWOT分析]についてメールでお問い合わせはこちら